Delivery Order SPE2DR25D2014-SPE2DR26FA1L4
Award Date 1/6/26
Potential Completion Date 1/7/26
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,323.06 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Suboxone 8 mg-2 mg sublingual film in quantities of 30, with a completion date of June 23, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price transaction and is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The product will be performed at the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for buprenorphine-naloxone 8-2mg film in 30-count packages, with a ceiling value of $1,064.64 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery...
- This delivery order, awarded on August 6, 2025, represents a $1,024.13 firm fixed-price purchase of Buprenorphine-Naloxone 8-2mg film (30-count) from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The order is being fulfilled at the vendor's Conshohocken location and will be completed by August 7, 2025. The contract was competitively awarded with no set-aside designation and is funded through the Defense Logistics Agency's Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,389.00 to AmerisourceBergen Drug Corp for the supply of Buprenorphine 0.3 mg/ml vials. The contract was competitively awarded without set-aside designation and is structured as a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Buprenorphine 0.3 mg/mL vials valued at $1,058.70. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 30, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is a child contract under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Zubsolv 2.9-0.71 mg tablet sublingual units in quantities of 30 with a ceiling value of $1,756.80. This is a firm fixed-price delivery order with an ultimate completion date of October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Buprenorphine 0.3 mg/mL vials with a ceiling value of $5,556.00. This is a firm fixed-price delivery order issued on August 26, 2025, with an ultimate completion date of August 27, 2025. The award was not set aside and represents a competitive award to the prime contractor. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery...
- This federal contract award, with an ID of SPE2DX15D1053|SPE2DX24F6NHR, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,362.12 fixed-price delivery order is for the supply of 4564829344 units of the pharmaceutical product BUPRENORPHINE-NALOX 2-0.5MG FM 30S. The contract has an ultimate completion date of June 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a...
- The Defense Logistics Agency issued a delivery order valued at $2,180.68 to AmerisourceBergen Drug Corp for the supply of Belbuca 900 mcg film (60-count package), a buprenorphine transdermal product used for pain management. This competitively awarded, firm fixed price delivery order was placed on August 1, 2025, with an ultimate completion date of August 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at approximately $137,000 to Amerisourcebergen Drug Corporation for the provision of 8 mg buprenorphine tablets. The firm fixed price order calls for the delivery of 30 boxes containing buprenorphine tablets to a facility in Conshohocken, Pennsylvania, with performance required between July 18-19, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this award supports the DLA's...